483
IndeCon, Inc.IndeCon, Inc. – FDA 483, Dec 12, 2024
Record Details
An FDA inspection of IndeCon, Inc. in Dallas, TX, an HCT/P distributor, revealed significant deficiencies in record-keeping and storage temperature monitoring. The firm failed to maintain records concurrently, document incoming product evaluations, record HCT/P storage temperatures, and retain all required records for the specified duration. These issues indicate a lack of adequate control over critical processes for human cells, tissues, and cellular and tissue-based products.
View Company Profile
ID · db291714-ce65-4a64-bdee-75da2f56c89f
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.